Journal
CELLULAR AND MOLECULAR NEUROBIOLOGY
Volume 41, Issue 7, Pages 1395-1411Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10571-020-00914-2
Keywords
Parkinson's disease; Parkin; Mitochondrial biogenesis; Mitochondrial dynamics; Mitophagy
Categories
Funding
- National Natural Science Foundation of China [81473376]
- Scientific Research In-depth Development Fund of Beijing University of Chinese Medicine [2019-ZXFZJJ-074]
- CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-004]
- Drug Innovation Major Project [2018ZX09711001-003-005, 2018ZX09711001-009-013]
Ask authors/readers for more resources
Parkinson's disease, a complex neurodegenerative disorder affecting millions of aged individuals, has been linked to mitochondrial dysfunction. Mutations in genes associated with PD, such as Parkin, have been found to play a crucial role in mitochondrial quality control, suggesting potential therapeutic targets for the disease.
Parkinson's disease (PD), as one of the complex neurodegenerative disorders, affects millions of aged people. Although the precise pathogenesis remains mostly unknown, a significant number of studies have demonstrated that mitochondrial dysfunction acts as a major role in the pathogeny of PD. Both nuclear and mitochondrial DNA mutations can damage mitochondrial integrity. Especially, mutations in several genes that PD-linked have a closed association with mitochondrial dysfunction (e.g., Parkin, PINK1, DJ-1, alpha-synuclein, and LRRK2). Parkin, whose mutation causes autosomal-recessive juvenile parkinsonism, plays an essential role in mitochondrial quality control of mitochondrial biogenesis, mitochondrial dynamics, and mitophagy. Therefore, we summarized the advanced studies of Parkin's role in mitochondrial quality control and hoped it could be studied further as a therapeutic target for PD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available